Report - Generierung humaner Antikörper-Spezifitäten zur Therapie ... · Tositumomab-I131 Bexxar® CD20 Non-Hodgkin Lymphom radiolabeled Efalizumab Raptiva® CD11a Psoriasis Cetuximab Erbitux®

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form